04:40 PM EDT, 10/13/2025 (MT Newswires) -- Maia Biotechnology ( MAIA ) said Monday it agreed to sell 603,769 shares at $1.22 each in a private placement to accredited investors, for expected gross proceeds of about $736,600.

Each share is being offered together with a warrant to buy one share at an exercise price of $1.52.

The private placement is expected to close on or about Wednesday.

Net proceeds will be used to fund the execution of step 1 of part C of the phase 2 trial of THIO-101 and for working capital, according to the company.